# RNA Bio/Pharma Inc – FDA Inspection, May 24, 2013

Source: https://www.keypedia.com/records/fda_inspections/rna-biopharma-inc/2761eafe-63ef-4139-ac28-4ccbb5ca4b39
Source feed: FDA_Inspections

> FDA inspection 834118 of RNA Bio/Pharma Inc, May 24, 2013. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 834118
- Company Name: RNA Bio/Pharma Inc
- Inspection Date: 2013-05-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1266530 - 2025-04-11](https://www.keypedia.com/records/fda_inspections/rna-biopharma-inc/c7c1c61f-a078-481e-a9be-bf3a44e4cb45)
- [FDA Inspection 1097487 - 2019-06-25](https://www.keypedia.com/records/fda_inspections/rna-biopharma-inc/58bd4338-cb62-4236-a20d-dc658eeaeb9d)
- FDA Inspection 1030091 - 2017-09-20
- [FDA Inspection 546350 - 2008-10-31](https://www.keypedia.com/records/fda_inspections/rna-biopharma-inc/cc9c040b-95a3-4a1e-bbbe-b8b245927f41)

Company: https://www.keypedia.com/companies/rna-biopharma-inc/eacb25ab-7668-444a-be5f-52117a9e5b63

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c